support@custommarketinsights.com+1 737 734 2707
  1. Home
  2. Press releases
  3. Global Genetic Engineering Market Size Likely to Expand at a…
Press release · Healthcare

Global Genetic Engineering Market Size Likely to Expand at a CAGR of 6.74% By 2033

Veena JagtapSr. Research AnalystPublished Source Custom Market Insights

Key highlights

  • The market dynamics are primarily influenced by key drivers, including the rising demand for biopharmaceuticals.
  • The market is also bolstered by technological advancements in gene editing tools like CRISPR-Cas9, which offer precise and efficient modifications to genetic sequences.
  • However, the market faces challenges such as ethical and regulatory concerns associated with altering genetic material.

Global Genetic Engineering Market size was valued at USD 1,491.6 Million in 2024 and is expected to reach USD 2,917.2 Million by 2033, at a CAGR of 6.74% during the forecast period 2024 - 2033.

$1.49 BnMarket size, 2024
$2.92 BnForecast, 2033
6.74%CAGR, 2024-2033

Genetic Engineering Market Overview

The Global Genetic Engineering Market is experiencing robust growth driven by advancements in biopharmaceuticals, gene editing technologies, and expanding applications in agriculture and personalized medicine. Genetic engineering involves manipulating an organism's genes to create desired traits, such as pest resistance in crops or targeted therapies for diseases.

Global Genetic Engineering Market 2024–2033 (By Million)
01,0002,0003,0002023: 1,4001,40020232024: 1,4921,49220242025: 1,7031,70320252026: 1,8551,85520262027: 2,0072,00720272028: 2,1592,15920282029: 2,3102,31020292030: 2,4622,46220302031: 2,6142,61420312032: 2,7652,76520322033: 2,9172,9172033USD Million

Source: Custom Market Insights analysis.

The market dynamics are primarily influenced by key drivers, including the rising demand for biopharmaceuticals. Genetic engineering enables the production of complex proteins and antibodies used in treating diseases like cancer and diabetes. The market is also bolstered by technological advancements in gene editing tools like CRISPR-Cas9, which offer precise and efficient modifications to genetic sequences.

However, the market faces challenges such as ethical and regulatory concerns associated with altering genetic material. Stringent regulations can slow down product approvals, impacting market growth. Additionally, the high cost of research and development in genetic engineering presents a barrier to entry for many companies.

Despite these challenges, the market presents significant opportunities, especially in agriculture and personalized medicine. Genetically modified crops are increasingly adopted for improving yield and sustainability, while personalized medicine based on genetic makeup is poised to transform disease treatment.

North America leads the global market, driven by established biotechnology and pharmaceutical industries, robust research ecosystems, and favorable regulatory environments. In contrast, the Asia Pacific region is emerging as a rapidly growing market due to increasing investments, government support, and rising awareness of genetic therapies.

The market is segmented by products, devices, techniques, applications, and end-users. Genetic markers and PCR (Polymerase Chain Reaction) are among the dominant segments, reflecting their critical roles in genetic engineering applications. Gene editing techniques, particularly CRISPR-Cas9, are at the forefront due to their precision and versatility.

Biotechnology companies are the primary end-users, heavily invested in genetic engineering for drug development and agricultural biotechnology. Academic and research institutions also drive innovation in genetic engineering techniques.

Recent developments highlight the market's progress, including positive clinical trial results for CRISPR-based therapies, partnerships for developing disease-resistant crops, and FDA approvals for gene editing therapies targeting genetic disorders.

Report Scope

Feature of the Report Details
Market Size in 2024 USD 1,491.6 Million
Projected Market Size in 2033 USD 2,917.2 Million
Market Size in 2023 USD 1,400 Million
CAGR Growth Rate 6.74% CAGR
Base Year 2023
Forecast Period 2024-2033
Key Segment By Product, Devices, Techniques, Application, End-User and Region
Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options Request tailored purchasing options to fulfil your requirements for research.

CMI has comprehensively analyzed the Genetic Engineering market. The driving forces, restraints, challenges, opportunities, and key trends have been explained in depth to depict an in-depth scenario of the market. Segment wise market size and market share during the forecast period are duly addressed to portray the probable picture of this Genetic Engineering industry.

The competitive landscape includes key innovators, after market service providers, market giants as well and niche players which were studied and analyzed extensively concerning their strengths, weaknesses as well as value addition prospects. In addition, the Report covers key players profiling, market shares, mergers and acquisitions, consequent market fragmentation, new trends and dynamics in partnerships, and emerging business models.

List of the prominent players in the Genetic Engineering Market:

  • Merck KGaA (Germany)
  • Thermo Fisher Scientific Inc. (US)
  • GenScript (China)
  • Agilent Technologies (US)
  • PerkinElmer (US)
  • Lonza (Switzerland)
  • Tecan Life Sciences (Switzerland)
  • Sangamo Therapeutics (US)
  • Editas Medicine (US)
  • CRISPR Therapeutics AG (Switzerland)
  • Precision Biosciences (US)
  • Cellectis S.A. (France)
  • Intellia Therapeutics (US)
  • Bluebird Bio Inc. (US)
  • Regeneron Pharmaceuticals (US)
  • AMSBIO (England)
  • Creative Biogene (US)
  • Synthego Corporation (US)
  • Beam Therapeutics Inc. (US)
  • Caribou Biosciences Inc. (US)
  • Others

The Genetic Engineering Market is segmented as follows:

By Product

  • Biochemical
  • Genetic Markers

By Devices

  • PCR
  • Gene Gun
  • Gel Assemblies

By Techniques

  • Gene Splicing
  • Artificial Selection
  • Recombinant DNA Technology
  • Synthesizing DNA
  • Gene Editing
  • Others

By Application

  • Agriculture
  • Medical Industrial

By End-User

  • Biotechnology Companies
  • Pharmaceutical Manufacturers
  • Academic and Research Institutions
  • Others

Regional Coverage:

North America

  • U.S.
  • Canada
  • Mexico
  • Rest of North America

Europe

  • Germany
  • France
  • U.K.
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • New Zealand
  • Australia
  • South Korea
  • Taiwan
  • Rest of Asia Pacific

The Middle East & Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa

Latin America

  • Brazil
  • Argentina
  • Rest of Latin America

Rate this press release

Share this press release

About the author

Veena Jagtap

Sr. Research Analyst

Research Analyst at Custom Market Insights, specializing in market research, competitive analysis, industry trends, and growth opportunities. Focused on transforming complex data into actionable insights that drive strategic decision-making and business growth.

View profile and reports

About Custom Market Insights

Custom Market Insights is a market research and advisory company. It publishes syndicated reports across 18+ industries and delivers custom research, feasibility studies and market entry strategy for companies, investors and consultancies.

Sales and media enquiriessupport@custommarketinsights.com
+1 737 734 2707

###

Free sample

Get the sample report

Global Genetic Engineering Market: sample pages and table of contents by email.

Security codeCode didn’t load.

We use these details only to answer this request. Privacy policy